Keywords
routine EEG with video - epilepsy - diagnostic yield - seizures - resource-limited
settings
Introduction
Routine electroencephalography (EEG) with video (rVEEG) is a widely used, noninvasive,
and cost-effective neurodiagnostic tool. Typically performed over 20 to 30 minutes,
it is useful for detecting interictal epileptiform discharges (IEDs), which aid in
the diagnosis and classification of epilepsy.[1] Long-term video EEG (vEEG), conducted over several days in an epilepsy monitoring
unit, remains the gold standard for evaluating drug-resistant epilepsy and capturing
ictal events.[2] However, such continuous monitoring requires specialized infrastructure and trained
personnel, making it challenging to implement in low-resource settings.[3]
rVEEG offers a more accessible alternative in such environments. Although limited
in duration, prior studies have demonstrated its utility in capturing clinically meaningful
data, distinguishing epileptic from nonepileptic events, and aiding seizure classification.[4]
[5] It is also frequently used to evaluate altered mental status, behavioral disturbances,
and postcardiac arrest prognostication.[6] However, the diagnostic yield of routine EEG varies widely, with sensitivity for
detecting IEDs reported between 25 and 56%.[7] Diagnostic performance is particularly limited in adults and patients with focal
epilepsy, and there remains a risk of overinterpretation or false-positive findings
in the absence of clinical correlation.[8]
Despite its limitations, routine EEG continues to play a critical role in epilepsy
evaluation, especially where access to long-term monitoring and advanced imaging is
limited. While studies on EEG utility have largely originated from high-resource settings,
comprehensive data from low- and middle-income countries are valuable, as health care
infrastructure, referral patterns, and patient demographics can differ significantly.[9]
This study was conducted in a resource-constrained tertiary care center in North India,
where access to long-term vEEG and magnetic resonance imaging (MRI) is often limited.
We aimed to evaluate the diagnostic yield of rVEEG in this specific setting and to
explore whether clinical variables could predict abnormal EEG findings. By analyzing
real-world data from a diverse patient population, this study contributes practical
insights into optimizing EEG use in similar low-resource environments.
Materials and Methods
This retrospective observational study was conducted in the Department of Neurology
at All India Institutes of Medical Sciences (AIIMS), Raebareli, a tertiary care academic
hospital in northern India. The study included adult patients (aged 18 years and older)
who underwent rVEEG between November 2023 and January 2025. Ethical clearance was
obtained from the Institutional Ethics Committee prior to data collection. Both inpatients
and outpatients referred for EEG during this period were considered for inclusion.
Patients of either gender with clinical suspicion of seizure disorders, including
epileptic seizures, psychogenic nonepileptic seizures (PNES), or other paroxysmal
events, were eligible. Patients were excluded if they were younger than 18 years of
age, had poor-quality EEG recordings, were medically unstable during testing, or had
incomplete clinical records.
Clinical and demographic data were retrospectively obtained from EEG registers and
hospital medical records. Variables collected included age, gender, clinical diagnosis
at the time of referral, seizure type (classified according to the 2017 International
League Against Epilepsy [ILAE] criteria),[10] number of antiseizure medications (ASMs) prescribed at the time of the test, the
reason for EEG referral, imaging findings if available (computed tomography [CT]/MRI),
and final EEG findings. Clinical events captured during the recording were also documented,
including motor manifestations, awareness level, responsiveness, and postictal behaviors.
All EEGs were performed in a dedicated neurophysiology laboratory using the NIHON
KODEN V32 digital EEG system. A standard 32-channel configuration was used, and electrodes
were applied according to the international 10–20 electrode placement system. Bipolar,
referential, and average montages were used during interpretation. Each EEG session
lasted approximately 30 minutes and included simultaneous video recording to facilitate
clinical correlation. Patients were positioned in a semirecumbent posture in a quiet,
dimly lit room and were asked to keep their eyes gently closed unless otherwise instructed.
Activation procedures included eye opening and closing, hyperventilation (HV) for
3 minutes when feasible, and intermittent photic stimulation (IPS) using a strobe
lamp flashing at frequencies ranging from 1 to 35 Hz. Sleep deprivation was suggested
for some patients, but was not a routine requirement. No sedatives were administered
before or during the recording, although spontaneous sleep was observed in several
patients.
All EEGs were initially screened by a certified EEG technologist (ABRET R.EEG.T) to
ensure technical quality and identify notable features. Subsequently, a neurology
resident with EEG training interpreted the findings, and final approval was given
by a consultant neurologist with expertise in epilepsy. EEGs were categorized into
one of five diagnostic groups: normal EEG (no abnormalities), focal IEDs (sharp waves
or spikes localized to one region or hemisphere), generalized IEDs (bilaterally synchronous
spike-and-wave or polyspike discharges), focal slowing (suggestive of localized cerebral
dysfunction), and generalized slowing (indicating diffuse encephalopathy). Benign
variants such as small sharp spikes, 14- and 6-Hz positive bursts, wicket spikes,
and phantom spikes were excluded from the IED category.
Brain imaging reports (CT or MRI) were reviewed when available. The availability of
neuroimaging data was specifically noted for each patient, and patients were categorized
as having normal imaging, structural abnormalities (e.g., gliosis, atrophy, malformations),
or no available imaging data. Etiological classification of epilepsy was based on
ILAE guidelines and included structural, infectious, genetic, metabolic, immune, and
unknown categories.
Statistical Analysis
Data were compiled in Microsoft Excel and analyzed using SPSS version 27 (IBM Corp.,
Armonk, New York, United States). Continuous variables were reported as means with
standard deviations or medians with interquartile ranges, depending on distribution.
Categorical data were presented as frequencies and percentages. Comparisons between
groups were made using Student's t-test or Mann–Whitney U-test for continuous variables and chi-square or Fisher's exact test for categorical
variables. To identify factors associated with abnormal EEG findings, univariate logistic
regression analysis was conducted. A p-value of less than 0.05 was considered statistically significant.
Results
This retrospective study included a total of 347 adult patients who underwent rVEEG.
The majority of patients were male (n = 187, 53.8%), and the most represented age group was 18 to 30 years (n = 202, 58.2%) ([Table 1]). A younger age of seizure onset (<18 years) was seen in 144 patients (41.4%), and
most participants had no family history of seizures (99.1%) ([Table 2]).
Table 1
Demographic characteristics of the study participants
Variables
|
Frequency, n (%)
|
Age (y)
|
18–30
|
202 (58.2)
|
31–40
|
68 (19.6)
|
41–50
|
30 (8.6)
|
51–60
|
10 (2.9)
|
>60
|
37 (10.7)
|
Gender
|
Male
|
187 (53.8)
|
Female
|
160 (46.2)
|
Table 2
Details on history of seizure
Variables
|
Frequency, n (%)
|
Age at onset of first seizure (y)
|
<18
|
144 (41.4)
|
18–30
|
124 (35.7)
|
31–40
|
45 (13.0)
|
41–50
|
15 (4.3)
|
51–60
|
9 (2.6)
|
>60
|
10 (2.9)
|
Family history of seizure
|
Yes
|
3 (0.9)
|
No
|
344 (99.1)
|
Types of seizure
|
Generalized seizures
|
Tonic–clonic seizures (Grand Mal)
|
33 (9.5)
|
Absence seizures (Petit Mal)
|
6 (1.7)
|
Focal seizures
|
Focal aware seizures
|
18 (5.2)
|
Focal impaired awareness seizure
|
183 (52.7)
|
Focal with bilateral convulsive seizures
|
64 (18.4)
|
Unknown
|
43 (12.4)
|
Etiology of seizure
|
Structural
|
8 (2.3)
|
Infections
|
31 (8.9)
|
Vascular
|
12 (3.5)
|
Unknown
|
296 (85.3)
|
The most frequent clinical seizure type was focal impaired awareness seizures, documented
in 183 individuals (52.7%), followed by focal to bilateral tonic–clonic seizures (n = 64, 18.4%). Other less common types included focal aware seizures, generalized
tonic–clonic, and absence seizures. In 12.4% of cases, the seizure type could not
be classified due to limited clinical information ([Table 2]).
Etiologically, the underlying cause of seizures remained unknown in 85.3% (n = 296) of the study population. Among identifiable etiologies, infections such as
neurocysticercosis and tuberculoma accounted for 31 cases (8.9%), while structural
and vascular causes were seen in 2.3 and 3.5% of patients, respectively. Regarding
neuroimaging availability, data from CT or MRI scans were available for review in
74 patients. Of these 74 patients, 40 had within normal limits or normal imaging findings,
and 34 had other lesions or abnormality findings. Imaging data were not recorded or
unavailable for the remaining 273 patients.
With regard to treatment, most patients (n = 299, 86.2%) were on monotherapy with ASMs, while 37 patients (10.7%) were on dual
therapy. Only a few required three or more ASMs or were not on any treatment at all
([Table 3]).
Table 3
Details on ASMs
Numberof ASM
|
Frequency, n (%)
|
None
|
3 (0.9)
|
One
|
299 (86.2)
|
Two
|
37 (10.7)
|
Three
|
5 (1.4)
|
Four
|
1 (0.3)
|
Not applicable
|
2 (0.6)
|
Abbreviation: ASM, antiseizure medication.
The primary indication for EEG referral was the evaluation of suspected epileptic
seizures (n = 288, 83.0%). Other reasons included episodes of loss of consciousness (6.1%), abnormal
movements (5.5%), stroke (2.6%), and nonepileptic causes such as visual hallucinations
or presurgical evaluation ([Table 4]). EEG was recorded within 1 week of the most recent seizure in 283 patients (81.6%).
A drowsy or sleep state was achieved in 57.3% of the recordings, which likely increased
diagnostic yield. A representative EEG showing normal posterior dominant alpha rhythm
with appropriate reactivity to eye opening and closure is provided in [Fig. 1].
Fig. 1 A 10-second EEG recording from a 12-year-old awake male, demonstrating a posterior
dominant alpha rhythm during eye closure. The alpha activity attenuates with eye opening
and reappears with eye closure, indicating normal alpha reactivity, which reflects
intact posterior cortical function. EEG, electroencephalography.
Table 4
Details on EEG
Variables
|
Frequency, n (%)
|
Reason for EEG requisition
|
Seizures
|
288 (83.0)
|
Headache
|
5 (1.4)
|
Stroke
|
9 (2.6)
|
Loss of consciousness
|
21 (6.1)
|
Abnormal body movements
|
19 (5.5)
|
Plan to stop ASM
|
1 (0.3)
|
Surgery
|
2 (0.6)
|
Visual hallucination
|
1 (0.3)
|
DRE
|
1 (0.3)
|
Time between the EEG and the last episode of seizure
|
Less than a week
|
283 (81.6)
|
Less than a month
|
22 (6.3)
|
Less than 6 months
|
28 (81.)
|
Less than a year
|
8 (2.3)
|
More than a year
|
6 (1.7)
|
State during recording
|
Drowsy (A + D)
|
148 (42.7)
|
Sleep (A + D + S)
|
199 (57.3)
|
Recent EEG changes
|
Normal
|
217 (62.5)
|
Abnormal
|
Spike and wave
|
89 (25.6)
|
Sharp wave
|
30 (8.6)
|
Slow wave
|
11 (3.2)
|
Abbreviations: ASM, antiseizure medication; DRE, drug-resistant epilepsy; EEG, electroencephalography.
Out of 347 EEGs reviewed, 130 (37.5%) showed abnormalities ([Table 4]). The most common EEG abnormalities included spike-and-wave discharges (n = 89, 25.6%), followed by sharp waves (n = 30, 8.6%) and slow waves (n = 11, 3.2%). The remainder (62.5%) had normal EEGs. Based on standardized EEG classification,
focal IEDs were observed in 59 patients (17.0%) ([Fig. 2]) and generalized IEDs in 30 patients (8.6%) ([Fig. 3]). Focal slowing was noted in 22 patients (6.3%) and generalized slowing in 11 patients
(3.2%) ([Fig. 4]).
Fig. 2 Routine EEG of a 20-year-old woman demonstrating a normal background rhythm with
generalized spike-and-wave discharges predominantly over the frontal regions. The
corresponding MRI was reported as normal, with no structural abnormalities detected.
EEG, electroencephalography.
Fig. 3 A 22-year-old man presented with right temporal gliosis on neuroimaging. EEG revealed
intermittent spike-and-wave discharges localized to the right temporal region, consistent
with a focal epileptiform pattern. EEG, electroencephalography.
Fig. 4 A 58-year-old man presented with acute altered sensorium and confusion. His medical
history was unknown, and there were no signs of seizure activity. EEG revealed intermittent,
generalized delta slowing, suggestive of a diffuse cerebral dysfunction. EEG, electroencephalography.
The simultaneous video recording proved to be a valuable component, leading to a revision
or refinement of the initial clinical diagnosis in 7.5%[11] of patients. These revisions primarily involved distinguishing misclassified seizures,
identifying PNES, or recognizing other paroxysmal nonepileptic events such as movement
disorders. For patients diagnosed with PNES based on video correlation, this often
led to important changes in management, including the avoidance or discontinuation
of unnecessary ASMs.
To identify clinical predictors of abnormal EEG findings, a binary logistic regression
analysis was conducted ([Table 5]). However, no statistically significant associations were found between EEG abnormalities
and variables such as age group, gender, age at seizure onset, seizure type, etiology,
or time between the last seizure and EEG recording (p > 0.05 for all comparisons). This lack of correlation may reflect the heterogeneity
of the study population and limitations in seizure classification due to retrospective
data collection.
Table 5
Logistic regression to evaluate the predictors of EEG
Variables
|
EEG changes
|
UOR
|
p-Value
|
AOR
|
p-Value
|
Normal
|
Abnormal
|
Age (y)
|
18–30
|
128 (59.0)
|
69 (58.0)
|
1.032 (0.871–1.223)
|
0.712
|
1.049 (0.862–1.276)
|
0.634
|
31–40
|
44 (20.3)
|
21 (17.6)
|
41–50
|
15 (6.9)
|
14 (11.8)
|
51–60
|
9 (4.1)
|
1 (0.8)
|
>60s
|
21 (9.7)
|
14 (11.8)
|
Gender
|
Male
|
118 (54.4)
|
63 (52.9)
|
1.070 (0.683–1.676)
|
0.767
|
1.103 (0.694–1.752)
|
0.678
|
Female
|
99 (45.6)
|
56 (47.1)
|
1
|
–
|
–
|
–
|
Age at onset of first seizure (y)
|
<18
|
93 (42.9)
|
46 (38.7)
|
0.935 (0.827–1.056)
|
0.280
|
1.004 (0.799–1.261)
|
0.972
|
18–30
|
73 (33.6)
|
49 (41.2)
|
31–40
|
30 (13.8)
|
13 (10.9)
|
41–50
|
8 (3.7)
|
6 (5.0)
|
51–60
|
7 (3.2)
|
2 (1.7)
|
>60
|
6 (2.8)
|
3 (2.5)
|
Types of seizure
|
Generalized seizures
|
Tonic–clonic seizures (Grand Mal)
|
20 (9.2)
|
13 (10.9)
|
1.400 (0.536–3.654)
|
0.492
|
1.508 (0.567–4.016)
|
0.411
|
Absence seizures (Petit Mal)
|
4 (1.8)
|
2 (1.7)
|
1.077 (0.174–6.649)
|
0.936
|
0.989 (0.157–6.216)
|
0.991
|
Focal seizures
|
Focal aware seizures
|
12 (5.5)
|
6 (5.0)
|
1.077 (0.331–3.506)
|
0.902
|
1.113 (0.334–3.707)
|
0.861
|
Focal impaired awareness seizure
|
119 (54.8)
|
59 (49.6)
|
1.068 (0.516–2.212)
|
0.860
|
1.033 (0.491–2.174)
|
0.932
|
Focal with bilateral convulsive seizures
|
34 (15.7)
|
26 (21.8)
|
1.647 (0.716–3.788)
|
0.240
|
1.581 (0.676–3.696)
|
0.291
|
Unknown
|
28 (12.9)
|
13 (10.9)
|
1
|
–
|
–
|
–
|
Etiology of seizure
|
Structural
|
5 (2.3)
|
2 (1.7)
|
0.723 (0.138–3.792)
|
0.701
|
1.064 (0.185–6.107)
|
0.945
|
Infections
|
18 (8.3)
|
12 (10.1)
|
1.205 (0.559–2.599)
|
0.634
|
1.241 (0.561–2.742)
|
0.594
|
Vascular
|
6 (2.8)
|
1 (0.8)
|
0.301 (0.36–2.537)
|
0.270
|
0.282 (0.032–2.521)
|
0.258
|
Unknown
|
188 (86.8)
|
104 (87.4)
|
1
|
–
|
1
|
–
|
Time between EEG and last episode of seizure
|
Less than a week
|
174 (80.2)
|
103 (86.6)
|
0.812 (0.609–1.082)
|
0.155
|
0.793 (0.587–1.071)
|
0.130
|
Less than a month
|
15 (6.9)
|
5 (4.2)
|
Less than 6 months
|
17 (7.8)
|
8 (6.7)
|
Less than a year
|
6 (2.8)
|
2 (1.7)
|
More than a year
|
5 (2.3)
|
1 (0.8)
|
Abbreviations: EEG, electroencephalography; UOR, unadjusted odds ratio; AOR, adjusted
odds ratio.
Discussion
rVEEG remains a cornerstone diagnostic modality in the evaluation and management of
adult epilepsy. It is instrumental in identifying IEDs, classifying seizure types,
and distinguishing epileptic seizures from mimics such as PNES.[4] Our study assessed the diagnostic yield and referral patterns of rVEEG in a real-world,
resource-constrained tertiary care setting. Only 37.5% of EEGs were abnormal, with
34.2% showing epileptiform discharges. While a normal EEG does not rule out epilepsy,
this rate is comparable to diagnostic yields reported in various literature for initial
EEG recordings.
Our study revealed a high proportion (85.3%) of unknown etiology for seizures, significantly
higher than rates in developed countries where structural or genetic causes are more
frequently identified. This disparity directly reflects diagnostic challenges in resource-constrained
settings, primarily due to limited neuroimaging access. Out of 347 patients, only
74 had neuroimaging data available (40 normal, 34 with lesions), with 273 lacking
recorded imaging. This limited access to advanced modalities such as high-resolution
MRI often precludes definitive identification of subtle structural abnormalities.
For instance, in contrast to some studies from India that report 25 to 35% structural
etiology, our findings underscore the critical need for improved access to comprehensive
diagnostic tools to better classify etiologies in such regions.[12]
[13]
Most EEGs in our study were ordered specifically to detect epileptiform activity.
However, it is well established that IEDs may not appear on a single routine EEG,
even in patients with confirmed epilepsy. McGinty et al. emphasized the value of video
EEG in distinguishing PNES from epileptic seizures.[14] Similarly, our study found that approximately 20% of referrals were for suspected
PNES,[15] highlighting rVEEG's utility as a screening tool in outpatient settings where long-term
monitoring is not feasible. This utility was further demonstrated by the fact that
video correlation facilitated a revision or refinement of the initial clinical diagnosis
in 7.5%[11] of patients, supporting its role in differentiating seizure types during brief recordings.
This observation aligns with previous Indian studies by Srikumar et al and Nada et
al, which also demonstrated the utility of rVEEG in differentiating seizure types
during brief recordings.[16]
[17]
In our study, the majority of EEGs (81.6%) were performed within a week of the most
recent seizure occurrence. Despite the timely scheduling, our multivariable logistic
regression analysis did not identify a statistically significant association between
the time since the last seizure and the likelihood of receiving aberrant EEG data.
This is in contrast with earlier research. For example, a first seizure cohort study
discovered that EEGs performed within 24 hours of the incident revealed epileptiform
discharges in 51% of cases, compared to 34% when performed beyond 24 hours.[14]
[18] Another study involving 203 individuals with a history of seizures found that 77%
of EEGs were positive for epileptiform discharges when taken within 2 days; however,
only 41% would be positive if the seizure had occurred 7 or more days prior.[19] These variations could be due to variances in methodology, seizure categorization
accuracy, or demographic variables.[20]
All common activation procedures—sleep, HV, and IPS—were utilized in our recordings.
Among these, sleep activation had the highest yield, with IEDs seen in 57.3% of patients.
This supports prior findings that sleep enhances EEG sensitivity.[21]
[22] However, HV and IPS were less effective, consistent with previous studies reporting
yields of only 5.0 and 3.3%, respectively.[17] Still, both remain valuable for identifying specific epilepsy syndromes, such as
photosensitive epilepsy.
Most patients in our cohort (86.2%) were on monotherapy, with 12.4% on two or more
ASMs. We found no significant correlation between the number of ASMs and EEG abnormality,
unlike pediatric studies, where higher ASM usage correlated with increased epileptiform
activity.[23]
[24] This discrepancy could be due to differences in epilepsy type, disease duration,
and medication response. Notably, Guida et al reported that increasing ASMs in adults
with refractory epilepsy did not consistently reduce epileptiform activity.[23] Our findings support the notion that EEG abnormalities are not solely determined
by the number of ASMs and emphasize the need for tailored management and follow-up
strategies.
The timing of EEG recording in relation to seizure onset is critical for IED detection.[25] Pohlmann-Eden and Newton suggested a transient hyperexcitable state following seizures,
increasing the likelihood of detecting abnormalities on EEG recorded soon after an
event.[11] While early EEGs (within 24 hours) show higher yields, our study did not find a
statistically significant difference, possibly due to retrospective design or sample
variability.[26] Nevertheless, among patients scanned within a week of seizure onset, 86.6% of abnormal
EEGs were found in this subgroup.
A subset of patients (2.6%) were stroke survivors. While none exhibited epileptiform
discharges, diffuse slowing was observed, likely indicating encephalopathy rather
than active epileptogenesis.[27] This aligns with previous findings by Macdonell et al, who noted that routine EEG
in poststroke settings has limited value unless nonconvulsive seizures or altered
mental status are suspected.[28] In such cases, long-term EEG monitoring is preferred for higher sensitivity.
In comparison, a study by Tayeb et al from Saudi Arabia reported a 42.4% EEG abnormality
rate, with 14.6% of patients exhibiting epileptiform discharges. They found a significant
association between EEG abnormalities and a history of stroke, as well as the use
of multiple ASMs. In contrast, our findings emphasize the added diagnostic utility
of rVEEG correlation, which enhances the ability to distinguish epileptic from nonepileptic
events even in brief recordings. This makes it a cost-effective and practical tool,
particularly well suited for outpatient settings.[29]
Our cohort encompassed various seizure types, with focal impaired awareness seizures
(52.7%) being the most common, followed by focal to bilateral tonic–clonic seizures
(18.4%), focal aware seizures (5.2%), generalized tonic–clonic seizures (9.5%), and
absence seizures (1.7%). Interestingly, although focal seizures dominated clinically,
the most frequent EEG abnormality was generalized spike-and-wave discharges. This
clinical–electrophysiological mismatch could be due to limitations in seizure classification
in retrospective reviews, which rely on clinical notes rather than direct observation.
It underscores the diagnostic contribution of EEG in refining seizure classification,
especially in resource-limited contexts. Moreover, the predominance of focal epilepsies,
which tend to have a lower EEG yield than idiopathic generalized epilepsies (IGEs),
may partly explain our modest rate of IED detection. Myers et al found that IGEs were
strong predictors of IED presence on routine EEG, likely due to the higher rates of
myoclonic and absence seizures in younger individuals.[30]
[31]
Strengths and Limitations
Strengths and Limitations
This study's strengths include a relatively large adult sample from a tertiary care
hospital in a resource-limited setting, enhancing its relevance to similar clinical
environments. rVEEG enabled electroclinical correlation, aiding in the identification
of PNES and other nonepileptic events. Standardized EEG protocols and accepted classification
methods improved internal validity and allowed meaningful subgroup analysis. The diverse
patient population also supports generalizability.
However, as a retrospective study, it is limited by incomplete data and potential
selection bias. The short EEG duration (20–30 minutes) may have missed intermittent
or habitual events, and repeat EEGs were often not feasible. Neuroimaging was unavailable
in over half the cases, contributing to the high rate of unknown etiology. While video
captured clinical events in a subset of patients, and when present, significantly
aided diagnostic refinement, particularly in differentiating epileptic from nonepileptic
events. Lack of follow-up prevented outcome assessment, and some subgroup analyses
were underpowered.
Conclusion
In summary, rVEEG in adult patients demonstrates a modest yet clinically meaningful
diagnostic yield, particularly in resource-constrained settings. The addition of video
significantly improved diagnostic accuracy; notably, in 7.5% (26 patients), the diagnosis
was either revised or refined based on video correlation (e.g., distinguishing misclassified
seizures, PNES, or movement disorders). While no consistent clinical predictors of
abnormal EEG findings emerged, rVEEG remains a valuable tool for initial evaluation
and classification of seizure disorders. Optimizing patient selection and incorporating
activation procedures can further enhance its utility, ensuring appropriate and efficient
use of neurodiagnostic resources.